BG Medicine Announces Agreement with Boehringer Ingelheim Pharmaceuticals, Inc.WALTHAM, Mass. -- BG Medicine announced today that it has entered into an agreement with Boehringer Ingelheim Pharmaceuticals, Inc. BG Medicine will apply its Systems Pharmacology platform to elucidate e·lu·ci·date v. e·lu·ci·dat·ed, e·lu·ci·dat·ing, e·lu·ci·dates v.tr. To make clear or plain, especially by explanation; clarify. v.intr. To give an explanation that serves to clarify. tissue drug effects and discover circulating biomarkers for clinical application. BG Medicine will take a systems biology Systems biology, a field of study in the biosciences, focuses on the systematic study of complex interactions in biological systems. Particularly from 2000 onwards, the term is used widely in the biosciences, and in a variety of contexts. approach employing multiple platforms Refers to two or more operating environments, which typically include the CPU family and operating system. For example, if versions of a program run on Windows and the Macintosh, the software is said to support multiple platforms. to generate data for analyses in proprietary bioinformatics and statistical methods. Financial terms of the agreement were not disclosed. "We are pleased to enter into this agreement with Boehringer Ingelheim Pharmaceuticals, Inc., a global leader in the pharmaceutical industry," said Pieter Muntendam, M.D., President of BG Medicine. "This combination of elucidation e·lu·ci·date v. e·lu·ci·dat·ed, e·lu·ci·dat·ing, e·lu·ci·dates v.tr. To make clear or plain, especially by explanation; clarify. v.intr. To give an explanation that serves to clarify. of drug mechanism and biomarker discovery Biomarker discovery is the process by which biomarkers are discovered. It is a medical term. Many commonly used blood tests in medicine are biomarkers. The way that these tests have been found can be seen as biomarker discovery. illustrates how our integrated platform can be applied as an integral part of drug development." About BG Medicine BG Medicine is pioneering the commercial application of Systems Pharmacology, which is based on scientific advances in the Systems Biology field. Its advanced proprietary platform enables novel paths to new medicines through molecular fingerprinting of genes, proteins, and metabolites Metabolites Substances produced by metabolism or by a metabolic process. Mentioned in: Interactions combined with powerful bioinformatics integration to produce Systems Response Profiles(TM). These profiles, which combine information from multiple physiological compartments and often include thousands of distinct analyte levels, have enabled unprecedented molecular characterization of disease states and drug response. BG Medicine applies its novel approach through collaborations with leading pharmaceutical companies. For more information please visit www.bg-medicine.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion